Safety and Performance Study of the INGEVITY Lead

NCT ID: NCT01688843

Last Updated: 2020-03-10

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

1060 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-10-31

Study Completion Date

2019-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to gather data to establish the safety, performance and effectiveness of the INGEVITY pace/ sense leads.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objective of this study is to gather data to establish the safety, performance and effectiveness of the INGEVITY pace/ sense leads

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bradycardia Sinus Node Dysfunction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

INGEVITY lead

INGEVITY lead implant

Group Type EXPERIMENTAL

INGEVITY lead

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

INGEVITY lead

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject is willing and capable of providing informed consent
* Subject has a Class I or II indication for implantation of a single(VVI (R) only) or dual chamber pacemaker or a CRT-P system according to the ACC/AHA/HRS, or ESC guidelines
* Subject is willing and capable of participating in all testing/ visits associated with this clinical study at an approved clinical study center and at the intervals defined by this protocol
* Subject is age 18 or above, or of legal age to give informed consent specific to state and national law

Exclusion Criteria

* Subject has or has had any pacing or ICD system implants
* Subject has a sensitivity to dexamethasone acetate (DXA)
* Subject has a mechanical tricuspid heart valve
* Subject is enrolled in any other concurrent study, with the exception of local mandatory governmental registries and observational studies/registries
* Subjects with documented permanent or persistent AF where the physician intends to implant dual chamber pulse generator (single chamber VVIR pulse generators in these subjects is acceptable)
* Subject is currently on the active heart transplant list
* Subject has documented life expectancy of less than 12 months
* Women of childbearing potential who are or might be pregnant at the time of study enrollment or INGEVITY Lead implant
* Subjects currently requiring dialysis
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Boston Scientific Corporation

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Charles Love, MD

Role: PRINCIPAL_INVESTIGATOR

Johns Hopkins University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mercy Gilbert Medical Center

Gilbert, Arizona, United States

Site Status

Cardiovascular Consultants, LTD

Glendale, Arizona, United States

Site Status

Pima Heart Physicians, PC

Tucson, Arizona, United States

Site Status

Sharp Grossmont Hospital

La Mesa, California, United States

Site Status

Orange County Heart Institute

Orange, California, United States

Site Status

Eisenhower Medical Center

Rancho Mirage, California, United States

Site Status

Sharp Memorial Hospital

San Diego, California, United States

Site Status

Danbury Hospital

Danbury, Connecticut, United States

Site Status

Cardiology Associates of Fairfield County

Trumbull, Connecticut, United States

Site Status

West Florida Cardiology Network, LLC

Largo, Florida, United States

Site Status

University Community Hospital

Tampa, Florida, United States

Site Status

Wellstar Research Institute

Marietta, Georgia, United States

Site Status

St. Vincent's Hospital

Indianapolis, Indiana, United States

Site Status

Indiana University Health La Porte Hospital

La Porte, Indiana, United States

Site Status

University of Iowa Hospitals and Clinics

Iowa City, Iowa, United States

Site Status

Southern Kentucky Heart Institute

Bowling Green, Kentucky, United States

Site Status

Ochsner Clinic Foundation

New Orleans, Louisiana, United States

Site Status

Henry Ford Hospital

Detroit, Michigan, United States

Site Status

Michigan CardioVascular Institute

Saginaw, Michigan, United States

Site Status

HealthEast St. Joseph's Hospital

Saint Paul, Minnesota, United States

Site Status

Cardiovascular Associates of the Delaware Valley

Sewell, New Jersey, United States

Site Status

New York Methodist Hospital

Brooklyn, New York, United States

Site Status

Rochester General Hospital

Rochester, New York, United States

Site Status

Staten Island University Hospital

Staten Island, New York, United States

Site Status

Forsyth Medical Center

Winston-Salem, North Carolina, United States

Site Status

Aultman Hospital

Canton, Ohio, United States

Site Status

Lindner Center for Research and Education at Christ Hosp

Cincinnati, Ohio, United States

Site Status

University Hospital, Inc.

Cincinnati, Ohio, United States

Site Status

Ohio State University Medical Center

Columbus, Ohio, United States

Site Status

Northwest Ohio Cardiology Consultants

Toledo, Ohio, United States

Site Status

Coastal Cardiology

Charleston, South Carolina, United States

Site Status

Spartanburg Regional Medical Center

Spartanburg, South Carolina, United States

Site Status

South Austin Hospital

Austin, Texas, United States

Site Status

Heart Hospital of Austin

Austin, Texas, United States

Site Status

North Texas Heart Center

Dallas, Texas, United States

Site Status

Plaza Medical Center of Fort Worth

Fort Worth, Texas, United States

Site Status

Trinity Mother Frances Health System

Tyler, Texas, United States

Site Status

University of Utah Hospital and Clinics

Salt Lake City, Utah, United States

Site Status

Bon Secours Heart & Vascular Institute

Richmond, Virginia, United States

Site Status

PeaceHealth St. Joseph Medical Center

Bellingham, Washington, United States

Site Status

Monongalia General Hospital

Morgantown, West Virginia, United States

Site Status

Wheeling Hospital Inc.

Wheeling, West Virginia, United States

Site Status

Wheaton Franciscan Healthcare

Glendale, Wisconsin, United States

Site Status

St. Mary's Madison

Madison, Wisconsin, United States

Site Status

St. Andrew's War Memorial Hospital

Brisbane, Queensland, Australia

Site Status

The Prince Charles Hospital

Chermside, Queensland, Australia

Site Status

Medizinische Univ.-Kliniken Graz

Graz, , Austria

Site Status

AKH Linz

Linz, , Austria

Site Status

Klinikum Wels-Grieskirchen GmbH

Wels, , Austria

Site Status

Universitair Ziekenhuis Gent

Ghent, , Belgium

Site Status

AZ Groeninge Campus

Kortrijk, , Belgium

Site Status

Royal Columbian Hospital

New Westminster, British Columbia, Canada

Site Status

Hamilton General Hospital

Hamilton, Ontario, Canada

Site Status

Hopital Hotel Dieu du Centre Hospitalier de l'Universite de Montreal

Montreal, Quebec, Canada

Site Status

Skejby Sygehus

Aarhus, , Denmark

Site Status

Roskilde University Hospital

Roskilde, , Denmark

Site Status

CHU La Timone Hospital

Marseille, , France

Site Status

NCN Nouvelles Cliniques Nantaises

Nantes, , France

Site Status

Kardiologische Gemeinschaftspraxis Kaltofen Schubert Gerner

Chemnitz, , Germany

Site Status

Uniklinik Köln

Cologne, , Germany

Site Status

Universitätsklinikum Erlangen

Erlangen, , Germany

Site Status

Otto-von-Guericke-Universitaet Magdeburg

Magdeburg, , Germany

Site Status

Prince of Wales Hospital

Shatin, , Hong Kong

Site Status

Azienda Ospedaliera Universitaria Integrata di Verona

Verona, , Italy

Site Status

Institut Jantung Negara

Kuala Lumpur, , Malaysia

Site Status

University of Malaya Medical Centre

Kuala Lumpur, , Malaysia

Site Status

Centro Hospitalar do Porto - Hospital de Santo Antonio

Porto, , Portugal

Site Status

Hospital de Santarem

Santarém, , Portugal

Site Status

Hospital Clinico Y Provincial

Barcelona, , Spain

Site Status

Hospital Universitario Nuestra Senora de Candelaria

Santa Cruz de Tenerife, , Spain

Site Status

Hospital Doctor Peset

Valencia, , Spain

Site Status

Clinico de Valladolid

Valladolid, , Spain

Site Status

Sahlgrenska University Hospital

Gothenburg, , Sweden

Site Status

Karolinska University Hospital

Stockholm, , Sweden

Site Status

Chiang Mai Heart Center Medical School Hospital

Chiang Mai, , Thailand

Site Status

Basildon and Thurrock University Hospitals NHS

Basildon, Essex, United Kingdom

Site Status

Belfast City Hospital

Belfast, , United Kingdom

Site Status

Wrexham Maelor Hospital

Wrexham, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Australia Austria Belgium Canada Denmark France Germany Hong Kong Italy Malaysia Portugal Spain Sweden Thailand United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BSC-CDM00048360

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

EMRI SureScan™ Clinical Study
NCT00433654 COMPLETED NA